Assets The total asset as at December 31, 2019 was decreased in an amounting of Baht 182.30 million or 19.09 percent from year end 2018. Significant changes was included Trade and other receivable was
–19 Q1–20 VS Q4–19 (MB) (MB) % Cash and cash equivalent 357.1 190.2 166.9 87.7% Trade and other receivables 2,512.5 2,268.6 243.9 10.8% Inventories 1,244.8 745.9 498.9 66.9% Advance payment for products
losses as financial assets. The Company will measure fair value of all derivatives and recognised in profit and loss statement, while the credit losses is to consider as impairment of trade receivables
that has significant changes Balance by Quarter Change Q2–21 Q4–20 Q2–21 VS Q4–20 (MB) (MB) % Cash and cash equivalent 166.2 204.5 (38.3) (18.7) Trade and other receivables 3,729.8 2,633.9 1,095.9 41.6
Type 2 Transaction (List 1). DOD Biotech Public Company Limited (the “Company”) hereby notifies the significant resolutions passed by the Board of Directors’ Meeting No. 8/2018, held on December 19, 2018
particular plummeted due to lockdown measures implemented in several countries, including Thailand. Worse, exports contracted as a result of the moribund economies of Thailand’s trade partners. At the same
and to enhance the financial services with expertise in wealth management, digital banking and trade finance of CTBC Bank through Land and Houses Financial Group which consists of; - LH Financial Group
, the value of merchandise exports expanded at a slower rate as the result of the economic slowdown in major trading partners, and the effect of protectionist trade policies between the US and China. The